Total Payments
$53,232
2024 Payments
$18.97
Companies
5
Transactions
37
Payment Breakdown by Category
Other$32,585 (61.2%)
Travel$11,505 (21.6%)
Consulting$7,975 (15.0%)
Food & Beverage$1,167 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,585 | 11 | 61.2% |
| Travel and Lodging | $11,505 | 12 | 21.6% |
| Consulting Fee | $7,975 | 3 | 15.0% |
| Food and Beverage | $1,167 | 11 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $43,705 | 29 | $0 (2018) |
| F. Hoffmann-La Roche AG | $6,858 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $2,525 | 3 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $125.00 | 1 | $0 (2017) |
| Regeneron Pharmaceuticals, Inc. | $18.97 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.97 | 1 | Regeneron Pharmaceuticals, Inc. ($18.97) |
| 2018 | $21,167 | 12 | Astellas Pharma US Inc ($21,167) |
| 2017 | $32,046 | 24 | Astellas Pharma US Inc ($22,538) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.97 | General |
| 05/07/2018 | Astellas Pharma US Inc | — | Consulting Fee | Cash or cash equivalent | $3,125.00 | General |
| 03/22/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,990.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/22/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Travel and Lodging | In-kind items and services | $367.29 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/21/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,990.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/21/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Travel and Lodging | In-kind items and services | $367.29 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/22/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,655.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/22/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Travel and Lodging | In-kind items and services | $611.30 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/22/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Travel and Lodging | In-kind items and services | $274.09 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/22/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Travel and Lodging | In-kind items and services | $269.88 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/22/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $67.47 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/25/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/25/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/30/2017 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $665.00 | General |
| 12/01/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: Infectious Diseases | ||||||
| 11/29/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: Infectious Diseases | ||||||
| 11/29/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Infectious Diseases | ||||||
| 11/20/2017 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,350.00 | General |
| 11/08/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Travel and Lodging | In-kind items and services | $625.41 | General |
| Category: Infectious Diseases | ||||||
| 10/20/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Infectious Diseases | ||||||
| 10/19/2017 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $6,065.25 | General |
| Category: None | ||||||
| 10/19/2017 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $561.10 | General |
| Category: None | ||||||
| 10/19/2017 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $231.78 | General |
| Category: None | ||||||
| 10/12/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,990.00 | General |
| Category: Infectious Diseases | ||||||
| 09/18/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Travel and Lodging | In-kind items and services | $869.90 | General |
| Category: Infectious Diseases | ||||||
About Dr. Mark Frattini, MD
Dr. Mark Frattini, MD is a Medical Oncology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881665669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Frattini, MD has received a total of $53,232 in payments from pharmaceutical and medical device companies, with $18.97 received in 2024. These payments were reported across 37 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,585).
Ad
Practice Information
- Specialty Medical Oncology
- Location New York, NY
- Active Since 01/30/2006
- Last Updated 06/13/2016
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1881665669
Products in Payments
- Cresemba (Drug) $18,617
- CRESEMBA (Drug) $18,042
- Non-Covered Product (Drug) $6,858
- DIFICID (Drug) $125.00
- Developmental Compound $91.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in New York
Craig Thompson, Md, MD
Medical Oncology — Payments: $2.1M
Medical Oncology $2.1M
Andrew Seidman, Md, MD
Medical Oncology — Payments: $1.7M
Medical Oncology $1.7M
Dr. Joshua Richter, M.d, M.D
Medical Oncology — Payments: $1.6M
Medical Oncology $1.6M
Ghassan Abou-Alfa, Md, MD
Medical Oncology — Payments: $1.2M
Medical Oncology $1.2M
Edward Gelmann
Medical Oncology — Payments: $944,679
Medical Oncology $944,679
Miguel Perales, Md, MD
Medical Oncology — Payments: $759,555
Medical Oncology $759,555